Literature DB >> 20467926

[Diabetes and heart failure].

Christian A Schneider1, Roman Pfister, Erland Erdmann.   

Abstract

Heart failure is a common complication of type 2 diabetes and bears a poor prognosis. For patients with diabetes and heart failure the commonly accepted standards for diagnosis and treatment of heart failure are to be applied, although prospective diabetes- specific trials are lacking. The optimum HbA(1c) target value as well as the optimum blood glucoselowering treatment are not known. Due to an absence of prospective randomized trials the treatment should follow general therapeutic principles (low incidence of side effects, combination therapy, patient-friendly dosage, costs).

Entities:  

Mesh：

Year:  2010        PMID： 20467926     DOI： 10.1007/s00059-010-3337-z

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  55 in total

1.  The prevention of heart failure--a new agenda.

Authors:  J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

Authors:  George G Sokos; Lazaros A Nikolaidis; Sunil Mankad; Dariush Elahi; Richard P Shannon
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

4.  Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

Authors:  Prakash C Deedwania; Thomas D Giles; Michael Klibaner; Jalal K Ghali; Johan Herlitz; Per Hildebrandt; John Kjekshus; Jindrich Spinar; Jiri Vitovec; Hilary Stanbrook; John Wikstrand
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

5.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

6.  Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.

Authors:  Albert A Carr; Peter R Kowey; Richard B Devereux; Barry M Brenner; Björn Dahlöf; Hans Ibsen; Lars H Lindholm; Paulette A Lyle; Steven M Snapinn; Zhongxin Zhang; Jonathan M Edelman; Shahnaz Shahinfar
Journal:  Am J Cardiol       Date:  2005-10-17       Impact factor: 2.778

7.  Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.

Authors:  Silvio E Inzucchi; Frederick A Masoudi; Yongfei Wang; Mikhail Kosiborod; Joanne M Foody; John F Setaro; Edward P Havranek; Harlan M Krumholz
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

8.  Insulin resistance and risk of congestive heart failure.

Authors:  Erik Ingelsson; Johan Sundström; Johan Arnlöv; Björn Zethelius; Lars Lind
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

9.  Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).

Authors:  Michelle O'Donoghue; Patrick Kenney; Eveline Oestreicher; Saif Anwaruddin; Aaron L Baggish; Daniel G Krauser; Annabel Chen; Roderick Tung; Renee Cameron; James L Januzzi
Journal:  Am J Cardiol       Date:  2007-08-09       Impact factor: 2.778

10.  GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.

Authors:  Mohammad Hossein Noyan-Ashraf; M Abdul Momen; Kiwon Ban; Al-Muktafi Sadi; Yu-Qing Zhou; Ali M Riazi; Laurie L Baggio; R Mark Henkelman; Mansoor Husain; Daniel J Drucker
Journal:  Diabetes       Date:  2009-01-16       Impact factor: 9.461
View more
  3 in total

1.  [Cardiac rehabilitation--more than just for the garden plot?].

Authors:  B Maisch
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

2.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

3.  Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database.

Authors:  D Stoyanova; B Stratmann; A Schwandt; N Heise; S Mühldorfer; H-J Ziegelasch; A Zimmermann; D Tschoepe; R W Holl
Journal:  Diabet Med       Date:  2019-02-27       Impact factor: 4.359
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.